This trial is testing a new drug, FCN-159, to see if it can help treat patients with advanced solid tumors or neurofibromatosis type 1.
- Neurofibromatosis Type 1
- Plexiform Neurofibromas
5 Primary · 19 Secondary · Reporting Duration: Through study completion, an average of 2 years
Awards & Highlights
1 Treatment Group
1 of 1
160 Total Participants · 1 Treatment Group
Primary Treatment: FCN-159 · No Placebo Group · Phase 1 & 2
Who is running the clinical trial?
Age 2 - 70 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there numerous centers offering this research study in Canada?
"This clinical trial is running out of 4 sites across the country, including Detroit, Gainesville and Charleston. To reduce time spent traveling for patients enrolled in this study, it may be beneficial to choose a clinic closest to your home." - Anonymous Online Contributor
To what extent is the participant pool for this clinical trial expanding?
"Affirmative. Per the information housed on clinicaltrials.gov, this medical trial is in search of volunteer participants and was first launched on March 26th 2021. The study needs to find 160 patients from 4 different locations before it can be completed; its records were most recently updated on August 24th 2022." - Anonymous Online Contributor
Am I eligible to partake in the current investigation?
"This medical study is seeking 160 individuals between the ages of 2 and 70 diagnosed with Watson Syndrome. To qualify, applicants must meet one or more of the following criteria: have a body weight above 94 lbs/42.5 kg., possess axillary freckling or inguinal region freckles; be genetically confirmed to have an NF1 germline mutation (either from testing at the central laboratory for FCN-159-002 or documentation from a CLIA-approved centre); display six cafe-au-lait macules bigger than 0.5 cm pre-puberty, 1.5 cm post puberty; two neurof" - Anonymous Online Contributor
Is there an age requirement to participate in this medical study?
"As per the requirements of this trial, potential enrollees must be at least 2 years old and no older than 70." - Anonymous Online Contributor
Are there any opportunities currently available to volunteers for this research project?
"Clinicaltrials.gov affirms that this research is still actively looking for subjects to enrol, having been first posted on March 26th 2021 and most recently updated August 24th 2022." - Anonymous Online Contributor